Joe Guszkowski from Restaurant Business breaks down the biggest forces shaping the restaurant world this year, from economic pressures to growth opportunities.

Tune in for the AlphaNooner, Daily at 12:00 pm ET

Each weekday at 12:00 pm ET, join us live for the AdvisorShares AlphaNooner show (#alphanooner) where we discuss timely topics with experts.

We want you to join the conversation!
Live questions are welcome from X, YouTube, LinkedIn, Facebook, and Twitch.

Follow Us →
YouTube: @advisorshares
X: @advisorshares
LinkedIn: @advisorshares
Instagram: @advisorshares  
Facebook: @advisorshares

Join us with Todd Harrison, Founder & CIO of CB1 Capital Management, for insight on the cannabis investing landscape!

Tune in for the AlphaNooner, Daily at 12:00 pm ET
Each weekday at 12:00 pm ET, join us live for the AdvisorShares AlphaNooner show (#alphanooner) where we discuss timely topics with experts.

We want you to join the conversation!
Live questions are welcome from X, YouTube, LinkedIn, Facebook, and Twitch.

Follow Us →
YouTube: @advisorshares
X: @advisorshares
LinkedIn: @advisorshares
Instagram: @advisorshares  
Facebook: @advisorshares

Catch this AlphaNooner replay featuring Doug Drysdale, CEO of Cybin ($CYBN). Doug dives into Cybin's latest progress on psychedelic therapeutics, including key updates on CYB003 and CYB004, insights into the evolving biotech landscape, and why he's optimistic about the future of mental health treatments. 

Award-winning journalist Mattha Busby joins the AlphaNooner to talk psychedelics, public health, and where drug reform goes next. A Ferriss–UC Berkeley Psychedelic Journalism Fellow, Busby has been published in The Guardian, VICE, WIRED, TIME, and GQ, and is the author of Should All Drugs Be Legalized?

We cover the global momentum behind psychedelic medicine, the tension between science and policy, and what he’s learned reporting from the frontlines of reform. A must-listen for anyone tracking the future of mental health and drug laws.